Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics
GSK and Relation Therapeutics announce $110 million AI drug discovery partnership
00

GSK and Relation Therapeutics announce $110 million AI drug discovery partnership

Jul 30, 2026

Relation Therapeutics and GSK announce a research collaboration worth up to $110 million to generate human cellular datasets and train AI models, including the MORGAN platform, for drug target identification. The deal builds on a prior partnership targeting fibrotic diseases and osteoarthritis. GSK is expanding its artificial intelligence use and increasing research and development investments to boost its drug pipeline efficiency.

GSK-Relation AI drug discovery partnership

  • ▪The collaboration between Relation Therapeutics and GSK builds on an earlier partnership focused on fibrotic diseases and osteoarthritis
  • ▪Relation Therapeutics entered a research collaboration with GSK worth up to $110 million to generate human cellular datasets and train artificial intelligence models

AI-driven drug target identification

  • ▪Relation Therapeutics will generate large-scale datasets showing how human cells respond to genetic and drug interventions to identify potential new drug targets
  • ▪The datasets generated by Relation Therapeutics will be used to train artificial intelligence foundation models, including the MORGAN platform

GSK R&D investment strategy

  • ▪GSK is increasing investment in research and development to strengthen the company's drug pipeline
  • ▪GSK is expanding the use of artificial intelligence to improve the efficiency and success rate of drug discovery

1 source

Reuters
GSK, Relation Therapeutics sign up to $110 million AI drug discovery deal | Reuters
View source article

Story comments

Loading comments…

Related entities

United Kingdom

Related Projects

GSK

Topics

AI in drug discoveryAI for developers